𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Effects of MAP kinase inhibitors on epidermal growth factor-induced neoplastic transformation of human keratinocytes

✍ Scribed by Hideya Mizuno; Yong-Yeon Cho; Wei-Ya Ma; Ann M. Bode; Zigang Dong

Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
258 KB
Volume
45
Category
Article
ISSN
0899-1987

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

We previously reported data regarding the mechanism of neoplastic transformation in JB6 Cl41 mouse skin epidermal cells. However, experimental in vitro models for studying neoplastic transformation of human cells could provide further insight into the mechanisms of human cancer development. In this study, we have established a neoplastic transformation model with HaCaT cells, a human keratinocyte cell line, and showed the usefulness of this cell line for studying the mechanisms of neoplastic transformation. Epidermal growth factor (EGF) treatment induced a dose‐dependent anchorage‐independent cell transformation in HaCaT cells. Furthermore, PD98059, a mitogen‐activated protein (MAP) kinase/ERK kinase (MEK) inhibitor, or SP600125, c‐Jun N‐terminal kinase (JNK) inhibitor, decreased cell growth, EGF‐induced DNA synthesis and transformation. Unlike observations in the JB6 mouse epidermal cell model, SB203580, a stress‐activated protein kinase‐2/p38 α and β (p38) inhibitor, increased EGF‐induced transformation in HaCaT cells. These results suggest that extracellular‐signal regulated kinase (ERK), JNK, or p38 are implicated in EGF‐induced neoplastic transformation of human cells. © 2005 Wiley‐Liss, Inc.

📜 SIMILAR VOLUMES

The effects of type beta transforming gr
The effects of type beta transforming growth factor on proliferation and epidermal growth factor receptor expression in a human glioblastoma cell line
✍ Eirik Helseth; Geirmund Unsgaard; Are Dalen; Randi Vik 📂 Article 📅 1988 🏛 Springer US 🌐 English ⚖ 582 KB

Type beta transforming growth factor (B-TGF) is a potent growth inhibitor to many human tumor cell lines. Very little is known about the mechanism for this growth inhibitory action of B-TGF. We here report the effect of B-TGF on proliferation and epidermal growth factor receptor (R-EGF) expression i

Effects of tyrosine kinase inhibitor, er
Effects of tyrosine kinase inhibitor, erbstatin, on cell growth and growth-factor/receptor gene expression in human gastric carcinoma cells
✍ Naoki Takekura; Wataru Yasui; Eikai Kyo; Kazuhiro Yoshida; Takashi Kameda; Yasuh 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 French ⚖ 571 KB

The effect of tyrosine kinase inhibitor, erbstatin, on cell growth and mRNA expression of growth-factor/receptor system was examined in 6 human gastric-carcinoma cell lines. Erbstatin inhibited both EGF-induced and serum-stimulated cell growth of all 6 cell lines (TMK-I, MKN-I, -7, -28, -45, -74) in

Effects of inhibitors of signal transduc
Effects of inhibitors of signal transduction pathways on transforming growth factor B1 and osteogenic protein-1-induced insulinlike growth factor binding protein-3 expression in human bone cells
✍ Narasimhan Srinivasan; David J. Baylink; Kuber Sampath; Subburaman Mohan 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 202 KB 👁 2 views

Signal transduction initiated by TGFb1 and OP-1 was studied in MG63 human osteosarcoma cells and in normal human bone cells (HBCs) in the presence of inhibitors of signal transduction events, using insulinlike growth factor binding protein-3 (IGFBP-3) production as an end point. Treatment of serum-f